New injection aims to restore hearing in stubborn cases
NCT ID NCT06437054
First seen May 12, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This early-stage study tests a new way to deliver medication directly into the ear for people with hearing loss that hasn't improved with standard treatments. About 26 adults with sudden, Meniere's, or noise-induced hearing loss will receive the injection. Researchers will check if the drug stays in the ear longer and helps improve hearing, while monitoring for side effects like eardrum healing time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEARING LOSS, SENSORINEURAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.